Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Good adherence to these medications further improved survival outcomes.
Access to health care without financial barriers helped narrow the gap between Black and white patients.
The guaiac fecal occult blood test (gFOBT), done every one or two years, was particularly effective at reducing colorectal cancer in men.
National LGBT Cancer Network releases largest-ever survey of LGBTQIA+ cancer survivors.
The National Comprehensive Cancer Network publishes a new guide that includes updated patient guidelines for colon and rectal cancers.
The early cancer is detected, the easier it is to treat.
Everyone with cancer deserves state-of-the-art care and a chance to live the best life possible.
Native American artist and writer Robert DesJarlait is a member of the Red Lake Ojibwe tribe and a colon cancer survivor and advocate.
FIT (fecal immunochemical testing), which tests for hidden blood in the stool, is an inexpensive home health test for colorectal cancer.
Braftovi plus Erbitux improved survival for people with previously treated advanced colorectal cancer.
New expert guidelines recommend that individuals of average risk for colorectal cancer begin screening exams at 45 instead of 50.
Excess weight, which is often linked to metabolic abnormalities, can contribute to a wide variety of health problems.
Women who frequently drank sugary beverages as adolescents were at particular risk of developing colon cancer before age 50.
The GI Genius aids clinicians in detecting potential irregularities during colon cancer screening and surveillance.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.